期刊文献+

术前短疗程放化疗对进展期低位直肠癌治疗的价值 被引量:2

暂未订购
导出
出处 《实用临床医药杂志》 CAS 2005年第7期103-103,105,共2页 Journal of Clinical Medicine in Practice
  • 相关文献

参考文献6

二级参考文献19

  • 1陈军.进展期胃肠道恶性肿瘤术后早期腹腔内化疗[J].癌症,1994,13(3):271-274. 被引量:33
  • 2陈易人,汪良.提高大肠癌远期疗效的措施[J].普外基础与临床杂志,1996,3(4):227-228. 被引量:16
  • 3柴志康.直肠癌术后局部复发的早期诊断和再切除[J].中华外科杂志,1996,7:395-397.
  • 4Williams N S,Johnston D.Reappyaisal of the 5 centimeter rule of distal excision for carcinoma of the rectum:a study of distal intramural spreed and of patients survival[J].Br J Surg,1983,70 (2):150.
  • 5Wess J L.How long is the five centimeter margin[J].Surg Gynecol Obseet,1986,163(2):101.
  • 6Leather A J M,Kocjan G,Savage F,et al.Detection of free malignant cells in the peritoneal cavity before and after resection of colorectal cancer.Dis Colon Rectum,1994,37:814.
  • 7Lai CL, Chien RN, Leung NW, et al. A one-year trial of lamivudine for chronic hepatitis B[J]. N Engl J Med, 1998,339(2):61~68.
  • 8Miles WE.A method of performing abdominal-perineal excision for carcinoma of the rectum and of the terminal portion of the pelvic colon. Lancet ⅱ , 1908:1812-1813.
  • 9Heald RJ, Chir M, Karanjia NS. Result of radical surgery for rectal cancer. World J Surg, 1992,16:848-857.
  • 10Parks AG. Transanal technique in low rectal anastomoses. Proc R Soc Med, 1972,65:975-976.

共引文献29

同被引文献15

  • 1徐建明,朱步东,Mangia Anita,Simone Gianni,Montemurro Severino,Giuliani Francesco,Maiello Evaristo,Colucci Giuseppe,Paradiso Angelo.胸苷酸合成酶和拓扑异构酶-1及Ki-67对伊立替康联合5-氟脲嘧啶治疗晚期大肠癌的预测价值[J].中华肿瘤杂志,2005,27(5):312-315. 被引量:9
  • 2Cersosimo RJ. Irinotecan: a new antineoplastic agent for the management of colorectal cancer. Ann Pharmacother, 1998, 32 :1324-1333.
  • 3Rothenberg ML. Efficacy and toxicity of irinotecan in patients with colorectal cancer. Semin Oncol, 1998, 25 (5 Suppl 11 ) : 39-46.
  • 4Kohne CH, van Cutsem E, Wils J, et al. Phase Ⅲ study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European organization for research and treatment of cancer gastrointestinal group study 40986. J Clin Oncol, 2005, 23 : 4856-4865.
  • 5Quintela-Fandino M, Gravalos C, Gonzalez E, et al. Irinotecan(CPT-11 )-based chemotherapy as induction treatment for advanced colorectal cancer. Anticancer Drugs, 2005,16 : 31-38.
  • 6Stein DE, Mahmoud NN, Anne PR, et al. Longer time interval between completion of neoadjuvant chemoradiation and surgical resection does not improve downstaging of rectal carcinoma. Dis Colon Rectum, 2003, 46: 448-453.
  • 7Douillard JY, Cunningham D, Roth AD, et al. Irinoteean combined with fluorouraeil compared with fluorouraeil alone as first-line treatment for metastatic eoloreetal cancer: A muhieentre randomized trial. Lancet, 2000, 355 : 1041-1047.
  • 8Sahz LB, Cox JV, Blanke C, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med, 2000,343 : 905-914.
  • 9Masi G, Cupini S, Marcucci L, et al. Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer. Ann Surg Oncol, 2006, 13: 58-65.
  • 10Ho WM, Ma B, Mok T, et al. Liver resection after irinotecan, 5-fluorouracil, and folinic acid for patients with unresectable colorectal liver metastases: a muhicenter phase Ⅱ study by the Cancer Therapeutic Research Group. Med Oncol, 2005, 22: 303-312.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部